| Trial Identifier: | D8223C00013 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04768985 |
| Start Date: | February 2021 |
| Primary Completion Date: | May 2021 |
| Study Completion Date: | May 2021 |
| Condition: | Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version |
| Country | Location |
|---|---|
| United States of America, CA | Glendale, CA, United States of America, 91206 |
| United States of America, MD | Brooklyn, MD, United States of America, 21225 |
| United States of America, UT | Salt Lake City, UT, United States of America, 84107 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company